EHS
EHS

As Q2 revenue takes expected dip, NeuroMetrix looks to recoup with updated product launch, GSK partnership

Earnings reports shared by neurostimulation and digital medicine company NeuroMetrix during a Q2 investors’ call showed a slight drop in total revenue as the company is preparing to place its marketing weight behind the launch of its updated wearable pain relief product, Quell. However, the company remained profitable during the quarter thanks to sales of its other product, DPNCheck.
EHS
Back to top button